In addition, a randomized controlled studies have shown that eplerenone reduces NT-proBNP levels in patients with worsening chronic heart failure and diabetes mellitus and/or chronic kidney disease (Filippatos et al., 2016). Here, NPPB is linked to chronic kidney disease.